Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 21

1.

Radiation Recall in a Patient with Intrahepatic Cholangiocarcinoma: Case Report and a Literature Review.

Bahaj W, Ya'qoub L, Toor M, Masood A.

Cureus. 2019 Jun 27;11(6):e5020. doi: 10.7759/cureus.5020.

2.

Evolving Clinical Utility of Liquid Biopsy in Gastrointestinal Cancers.

Jacobson RA, Munding E, Hayden DM, Levy M, Kuzel TM, Pappas SG, Masood A.

Cancers (Basel). 2019 Aug 13;11(8). pii: E1164. doi: 10.3390/cancers11081164. Review.

3.

Emergence of ERBB2 Mutation as a Biomarker and an Actionable Target in Solid Cancers.

Subramanian J, Katta A, Masood A, Vudem DR, Kancha RK.

Oncologist. 2019 Jul 10. pii: theoncologist.2018-0845. doi: 10.1634/theoncologist.2018-0845. [Epub ahead of print] Review.

PMID:
31292270
4.

Pembrolizumab in newly diagnosed EBV-negative extranodal natural killer/T-cell lymphoma: A case report.

Asif S, Begemann M, Bennett J, Fatima R, Masood A, Raza S.

Mol Clin Oncol. 2019 Mar;10(3):397-400. doi: 10.3892/mco.2019.1805. Epub 2019 Jan 23.

5.

Comparative proteogenomic analysis of right-sided colon cancer, left-sided colon cancer and rectal cancer reveals distinct mutational profiles.

Imperial R, Ahmed Z, Toor OM, Erdo─čan C, Khaliq A, Case P, Case J, Kennedy K, Cummings LS, Melton N, Raza S, Diri B, Mohammad R, El-Rayes B, Pluard T, Hussain A, Subramanian J, Masood A.

Mol Cancer. 2018 Dec 21;17(1):177. doi: 10.1186/s12943-018-0923-9.

6.

Recurrent WNT pathway alterations are frequent in relapsed small cell lung cancer.

Wagner AH, Devarakonda S, Skidmore ZL, Krysiak K, Ramu A, Trani L, Kunisaki J, Masood A, Waqar SN, Spies NC, Morgensztern D, Waligorski J, Ponce J, Fulton RS, Maggi LB Jr, Weber JD, Watson MA, O'Conor CJ, Ritter JH, Olsen RR, Cheng H, Mukhopadhyay A, Can I, Cessna MH, Oliver TG, Mardis ER, Wilson RK, Griffith M, Griffith OL, Govindan R.

Nat Commun. 2018 Sep 17;9(1):3787. doi: 10.1038/s41467-018-06162-9.

7.

Tumor Mutation Burden as a Biomarker in Resected Non-Small-Cell Lung Cancer.

Devarakonda S, Rotolo F, Tsao MS, Lanc I, Brambilla E, Masood A, Olaussen KA, Fulton R, Sakashita S, McLeer-Florin A, Ding K, Le Teuff G, Shepherd FA, Pignon JP, Graziano SL, Kratzke R, Soria JC, Seymour L, Govindan R, Michiels S.

J Clin Oncol. 2018 Oct 20;36(30):2995-3006. doi: 10.1200/JCO.2018.78.1963. Epub 2018 Aug 14.

PMID:
30106638
8.

The evolving genomic landscape in urothelial cancer.

Kujtan L, Hussain A, Subramanian J, Masood A.

Curr Opin Oncol. 2018 May;30(3):197-202. doi: 10.1097/CCO.0000000000000447. Review.

PMID:
29538042
9.

Correlation of Somatic Genomic Alterations Between Tissue Genomics and ctDNA Employing Next-Generation Sequencing: Analysis of Lung and Gastrointestinal Cancers.

Toor OM, Ahmed Z, Bahaj W, Boda U, Cummings LS, McNally ME, Kennedy KF, Pluard TJ, Hussain A, Subramanian J, Masood A.

Mol Cancer Ther. 2018 May;17(5):1123-1132. doi: 10.1158/1535-7163.MCT-17-1015. Epub 2018 Mar 2.

10.

The Role of Systemic Therapy in the Management of Stage I Large Cell Neuroendocrine Carcinoma of the Lung.

Kujtan L, Muthukumar V, Kennedy KF, Davis JR, Masood A, Subramanian J.

J Thorac Oncol. 2018 May;13(5):707-714. doi: 10.1016/j.jtho.2018.01.019. Epub 2018 Jan 31.

11.

Comprehensive pancancer genomic analysis reveals (RTK)-RAS-RAF-MEK as a key dysregulated pathway in cancer: Its clinical implications.

Imperial R, Toor OM, Hussain A, Subramanian J, Masood A.

Semin Cancer Biol. 2019 Feb;54:14-28. doi: 10.1016/j.semcancer.2017.11.016. Epub 2017 Nov 22. Review.

PMID:
29175106
12.

Predictors for chemotherapy in early stage small cell lung carcinoma (SCLC): A National Cancer Database (NCDB) analysis.

Ahmed Z, Grover P, Kennedy KF, Masood A, Davis JR, Subramanian J.

Lung Cancer. 2017 Nov;113:85-87. doi: 10.1016/j.lungcan.2017.09.004. Epub 2017 Sep 13. No abstract available.

PMID:
29110855
13.

Next-Generation Sequencing of Lung Cancers: Lessons Learned and Future Directions.

Devarakonda S, Masood A, Govindan R.

Hematol Oncol Clin North Am. 2017 Feb;31(1):1-12. doi: 10.1016/j.hoc.2016.08.008. Review.

PMID:
27912825
14.

Adjuvant Chemotherapy for Patients with T2N0M0 NSCLC.

Morgensztern D, Du L, Waqar SN, Patel A, Samson P, Devarakonda S, Gao F, Robinson CG, Bradley J, Baggstrom M, Masood A, Govindan R, Puri V.

J Thorac Oncol. 2016 Oct;11(10):1729-35. doi: 10.1016/j.jtho.2016.05.022. Epub 2016 Jun 8.

15.

A hot L1 retrotransposon evades somatic repression and initiates human colorectal cancer.

Scott EC, Gardner EJ, Masood A, Chuang NT, Vertino PM, Devine SE.

Genome Res. 2016 Jun;26(6):745-55. doi: 10.1101/gr.201814.115. Epub 2016 May 10.

16.

Syndrome of inappropriate anti-diuretic hormone in non-small cell lung carcinoma: a case report.

McDonald P, Lane C, Rojas GE, Masood A.

Ecancermedicalscience. 2012;6:279. doi: 10.3332/ecancer.2012.279. Epub 2012 Nov 14.

17.

Adherence to hepatitis B screening and prophylactic lamivudine for prevention of rituximab-associated hepatitis B reactivation.

Liu CY, Chandrasekar PH, Masood A, Schiffer CA.

J Oncol Pharm Pract. 2013 Mar;19(1):18-23. doi: 10.1177/1078155212447975. Epub 2012 May 25.

PMID:
22635416
18.

Small molecule inhibitors of bcl-2 family proteins for pancreatic cancer therapy.

Masood A, Azmi AS, Mohammad RM.

Cancers (Basel). 2011 Jun 1;3(2):1527-49. doi: 10.3390/cancers3021527.

19.

Progress in nanotechnology based approaches to enhance the potential of chemopreventive agents.

Muqbil I, Masood A, Sarkar FH, Mohammad RM, Azmi AS.

Cancers (Basel). 2011 Jan 21;3(1):428-45. doi: 10.3390/cancers3010428.

20.

Neurocognitive deficits in a patient with small cell lung cancer: a case report.

Hudhud KH, Masood A, Oh Y, Hegazi A.

Cases J. 2008 Oct 27;1(1):278. doi: 10.1186/1757-1626-1-278.

Supplemental Content

Loading ...
Support Center